392 related articles for article (PubMed ID: 26248360)
1. An Antifungal Benzimidazole Derivative Inhibits Ergosterol Biosynthesis and Reveals Novel Sterols.
Keller P; Müller C; Engelhardt I; Hiller E; Lemuth K; Eickhoff H; Wiesmüller KH; Burger-Kentischer A; Bracher F; Rupp S
Antimicrob Agents Chemother; 2015 Oct; 59(10):6296-307. PubMed ID: 26248360
[TBL] [Abstract][Full Text] [Related]
2. A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives.
Burger-Kentischer A; Finkelmeier D; Keller P; Bauer J; Eickhoff H; Kleymann G; Abu Rayyan W; Singh A; Schröppel K; Lemuth K; Wiesmüller KH; Rupp S
Antimicrob Agents Chemother; 2011 Oct; 55(10):4789-801. PubMed ID: 21746957
[TBL] [Abstract][Full Text] [Related]
3. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
Sanati H; Belanger P; Fratti R; Ghannoum M
Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
[TBL] [Abstract][Full Text] [Related]
4. Loss-of-Function
Ollinger TL; Vu B; Murante D; Parker JE; Simonicova L; Doorley L; Stamnes MA; Kelly SL; Rogers PD; Moye-Rowley WS; Krysan DJ
mSphere; 2021 Dec; 6(6):e0083021. PubMed ID: 34935446
[TBL] [Abstract][Full Text] [Related]
5. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
Keniya MV; Ruma YN; Tyndall JDA; Monk BC
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
[TBL] [Abstract][Full Text] [Related]
6. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
Hull CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2012 Aug; 56(8):4223-32. PubMed ID: 22615281
[TBL] [Abstract][Full Text] [Related]
7. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.
Onyewu C; Blankenship JR; Del Poeta M; Heitman J
Antimicrob Agents Chemother; 2003 Mar; 47(3):956-64. PubMed ID: 12604527
[TBL] [Abstract][Full Text] [Related]
8. Comparison of sterol import under aerobic and anaerobic conditions in three fungal species, Candida albicans, Candida glabrata, and Saccharomyces cerevisiae.
Zavrel M; Hoot SJ; White TC
Eukaryot Cell; 2013 May; 12(5):725-38. PubMed ID: 23475705
[TBL] [Abstract][Full Text] [Related]
9. Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Yu PK; Moron-Espiritu LS; Lao AR
mSystems; 2022 Dec; 7(6):e0069122. PubMed ID: 36383015
[TBL] [Abstract][Full Text] [Related]
10. Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery.
Keniya MV; Sabherwal M; Wilson RK; Woods MA; Sagatova AA; Tyndall JDA; Monk BC
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126961
[TBL] [Abstract][Full Text] [Related]
11. Titration of C-5 Sterol Desaturase Activity Reveals Its Relationship to Candida albicans Virulence and Antifungal Susceptibility Is Dependent upon Host Immune Status.
Regan J; DeJarnette C; Luna-Tapia A; Parker JE; Reitler P; Barnett S; Tucker KM; Kelly SL; Palmer GE
mBio; 2022 Apr; 13(2):e0011522. PubMed ID: 35380453
[TBL] [Abstract][Full Text] [Related]
12. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
13. Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species.
Domingues Bianchin M; Borowicz SM; da Rosa Monte Machado G; Pippi B; Stanisçuaski Guterres S; Raffin Pohlmann A; Meneghello Fuentefria A; Clemes Külkamp-Guerreiro I
Colloids Surf B Biointerfaces; 2019 Mar; 175():523-529. PubMed ID: 30579053
[TBL] [Abstract][Full Text] [Related]
14. The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.
Alvarez-Rueda N; Fleury A; Logé C; Pagniez F; Robert E; Morio F; Le Pape P
Med Mycol; 2016 Oct; 54(7):764-775. PubMed ID: 27143634
[TBL] [Abstract][Full Text] [Related]
15. High-Throughput Chemical Screen Identifies a 2,5-Disubstituted Pyridine as an Inhibitor of Candida albicans Erg11.
Du Bois AC; Xue A; Pham C; Revie NM; Meyer KJ; Yashiroda Y; Boone C; Nodwell JR; Stogios P; Savchenko A; Robbins N; Iyer KR; Cowen LE
mSphere; 2022 Jun; 7(3):e0007522. PubMed ID: 35531664
[TBL] [Abstract][Full Text] [Related]
16. Antifungals: Mechanism of Action and Drug Resistance.
Prasad R; Shah AH; Rawal MK
Adv Exp Med Biol; 2016; 892():327-349. PubMed ID: 26721281
[TBL] [Abstract][Full Text] [Related]
17. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
18. Species-Specific Differences in C-5 Sterol Desaturase Function Influence the Outcome of Azole Antifungal Exposure.
Luna-Tapia A; Parker JE; Kelly SL; Palmer GE
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0104421. PubMed ID: 34516249
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ergosterol synthesis by novel antifungal compounds targeting C-14 reductase.
Hata M; Ishii Y; Watanabe E; Uoto K; Kobayashi S; Yoshida K; Otani T; Ando A
Med Mycol; 2010 Jun; 48(4):613-21. PubMed ID: 20392153
[TBL] [Abstract][Full Text] [Related]
20. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
